CINECA IRIS Institutional Research Information System

LEO, MARENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.916
EU - Europa 1.070
AS - Asia 1.001
SA - Sud America 126
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.850
SG - Singapore 331
CN - Cina 313
SE - Svezia 287
IT - Italia 199
HK - Hong Kong 197
DE - Germania 147
BR - Brasile 107
BG - Bulgaria 92
GB - Regno Unito 92
FR - Francia 59
CA - Canada 50
AT - Austria 45
VN - Vietnam 44
CI - Costa d'Avorio 39
FI - Finlandia 39
RU - Federazione Russa 37
TR - Turchia 34
IN - India 32
SN - Senegal 20
UA - Ucraina 18
BE - Belgio 13
JP - Giappone 13
NL - Olanda 12
AR - Argentina 8
MX - Messico 7
PL - Polonia 7
SA - Arabia Saudita 7
BD - Bangladesh 5
ES - Italia 5
IE - Irlanda 4
IQ - Iraq 4
PH - Filippine 4
PK - Pakistan 4
ZA - Sudafrica 4
AU - Australia 3
EC - Ecuador 3
EU - Europa 3
LT - Lituania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ID - Indonesia 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
UY - Uruguay 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
RS - Serbia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.190
Salva come PNG Salva come JPEG
Città #
Ashburn 316
Fairfield 288
Woodbridge 286
Houston 266
Ann Arbor 234
Hong Kong 193
Dallas 172
Singapore 169
Santa Clara 159
Chandler 158
Seattle 135
Wilmington 103
Sofia 92
Cambridge 85
Beijing 78
Shanghai 75
Serra 67
New York 65
Los Angeles 47
Munich 43
Vienna 43
Boardman 40
Abidjan 39
London 39
Ottawa 37
Princeton 37
Lawrence 31
Medford 29
Bremen 26
Lancaster 24
Nanjing 24
Des Moines 23
Frankfurt am Main 23
Florence 22
Dakar 20
Dong Ket 18
Istanbul 17
Redondo Beach 16
Dearborn 15
Marseille 15
Ogden 15
Brussels 13
Turku 13
Fuzhou 12
Pisa 11
Chicago 10
Nanchang 10
San Diego 10
Tokyo 10
Toronto 10
Falls Church 9
Jacksonville 9
Hebei 8
Izmir 8
Rome 8
Chennai 7
Düsseldorf 7
Houten 7
Milan 7
Buffalo 6
Guangzhou 6
Helsinki 6
Kunming 6
Phoenix 6
Poplar 6
Warsaw 6
Atlanta 5
Changsha 5
Columbus 5
Ho Chi Minh City 5
Manchester 5
Orem 5
Stockholm 5
São Paulo 5
The Dalles 5
Tianjin 5
Ankara 4
Aosta 4
Jüchen 4
Kent 4
Ossé 4
Portsmouth 4
Rio de Janeiro 4
San Francisco 4
Boulder 3
Brooklyn 3
Da Nang 3
Denver 3
Elk Grove Village 3
Hangzhou 3
Hefei 3
Jeddah 3
Jiaxing 3
Jinan 3
Lucca 3
Mexico City 3
Ningbo 3
Pesqueira 3
Redwood City 3
Ribeirão Preto 3
Totale 3.925
Salva come PNG Salva come JPEG
Nome #
Natural history of graves’ orbitopathy after treatment 253
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 225
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 204
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 199
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 191
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 189
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 176
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 174
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 172
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 165
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 161
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 158
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 154
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 150
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 148
Thyroid volume and severity of graves' orbitopathy 146
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 142
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 141
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 139
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 133
Treatment options for Graves' orbitopathy. 129
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 124
null 121
null 120
Selenium in Graves Hyperthyroidism and Orbitopathy 118
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 118
Oxidative stress in graves' disease. 116
null 97
null 93
null 91
null 88
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 87
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 86
null 85
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 78
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 74
null 65
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 64
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 60
Total thyroid ablation in Graves' orbitopathy 44
Totale 5.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 10 19 29 26 31 20 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023613 64 119 54 51 46 67 6 48 118 0 37 3
2023/2024269 13 20 31 5 30 71 7 20 4 3 37 28
2024/20251.078 7 34 9 65 132 120 69 41 129 139 103 230
2025/2026761 117 145 151 104 151 93 0 0 0 0 0 0
Totale 5.278